Fonseca AAA, Naranjo FLL, Sánchez FSA, Suárez QA, Cordové GY

Language: Spanish
References: 15
Page:
PDF size: 264.25 Kb.

ABSTRACT

Introduction: chronic kidney disease and arterial hypertension constitute a public health problem. Hypertensive heart disease is within the spectrum of complications due to these two nosological entities.
Objective: to identify the influence of the different risk factors for the development of hypertensive heart disease in patients diagnosed with chronic kidney disease.
Methods: a case-control study was carried out in patients who were admitted to the Internal Medicine and Nephrology services, as well as HTA outpatients of the "Carlos Manuel de Céspedes" Provincial General Hospital of Bayamo in the period from the 1st from January 2019 to March 31, 2021.
Results: the binary logistic regression model adjusted by the backward stepwise method showed that only 11 variables were sufficient for an adequate fit of the model and adequate discriminative capacity (area under the curve: 0.945). The outstanding factors were, in order of importance, the non-control of hypertension, the time of evolution and the C-reactive protein.
Conclusions: a model is obtained to predict the development of hypertensive heart disease in patients with chronic kidney disease, with adequate discriminative capacity based on risk factors.

REFERENCES

1. Candelaria Brito JC, Gutiérrez Gutiérrez C, Bayarre Vea HD, Acosta Cruz C, Montes de Oca DM, Labrador Mazón O. Caracterización de la enfermedad renal crónica en adultos mayores. Rev. Colomb. Nefrol. 2018; 5(2): 166-78.

2. Chipi Cabrera JA, Fernandini Escalona E. Enfermedad renal crónica presuntiva en adultos mayores. Rev. Colomb. Nefrol. 2019; 6(2):138-51.

3. Peña Sánchez G, Álvarez Aliaga A, Varona Venta M, Martínez García Y. Factores asociados al desarrollo de la nefropatía hipertensiva. MULTIMED 2017; 21(4): 359-79.

4. Díez J, Laviades C. La cardiopatía hipertensiva en el paciente con enfermedad renal crónica. Nefrología 2008; 28(2): 135-42.

5. Platero Díaz A, Cruz Rodríguez J, Rodríguez Lora H. Presentación de alteraciones cardiovasculares en pacientes en diálisis. Archivos del Hospital Universitario General Calixto García. [Internet]. 2021 [citado 11/02/2022]; 9(1): [aprox. 14 p.]. Disponible en: http://revcalixto.sld.cu/index.php/ahcg/article/view/6765. .

6. Santos Treto Y, Ramos Cárdenas E, Trujillo Alemán R, Gutiérrez Medina H, Martínez Cuéllar Y, Ramírez Felipe L. Complicaciones cardiovasculares en pacientes con enfermedad renal crónica en hemodiálisis. Acta Médica del Centro 2016; 10(2): 23-30.

7. Pereira Rodríguez JE, Boada Morales L, Niño Serrato DR, Caballero Chavarro M, Rincón Gonzales G, Jaimes Martín T, et al. Síndrome cardiorrenal. Rev Colomb Cardiol 2017; 24(6): 602-13.

8. Nielsen TL, Plesner LL, Warming PE, Mortensen OH, Iversen KK, Heaf JG. FGF23 in hemodialysis patients is associated with left ventricular hypertrophy and reduced ejection fraction. Nefrologia (Engl Ed) 2019; 39(3): 258-68.

9. Akbari A, Clase CM, Acott P, Battistella M, Bello A, Feltmate P, et al. Canadian Society of Nephrology commentary on the KDIGO clinical practice guideline for CKD evaluation and management. Am J Kidney Dis 2015; 65(2): 177-205.

10. Álvarez Aliaga A, Frómeta Guerra A, Suárez Quesada A, del Llano Sosa D, Berdú Saumell J, Lago Santiesteban YA. Prognostic model of the adaptive changes from hypertensive cardiopathy: from mild diastolic dysfunction to depressed systolic function. Medwave 2020; 20(3): e7873.

11. Seferovic PM, Ponikowski P, Anker SD, Bauersachs J, Chioncel O, Cleland JGF, et al. Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2019; 21(10): 1169-86.

12. Whelton PK, Carey RM. The 2017 American College of Cardiology/American Heart Association Clinical Practice Guideline for High Blood Pressure in Adults. JAMA Cardiol 2018; 3(4): 352-3.

13. Fernández González EM, Figueroa Oliva DA. Tabaquismo y su relación con las enfermedades cardiovasculares. Rev haban cienc méd 2018; 17(2): 225-35.

14. Álvarez Aliaga A, Quesada Vázquez AJ, Suárez Quesada A, Llano Sosa D. de. Design and validation of an Index to predict the development of Hypertensive Cardiopathy. J Cardiol Cardiovasc Med 2018; 3: 08-022.

15. Peralta J, Sáenz C, Hernández E, Castillo Y, Mazariegos W. Proteína C reactiva ultrasensible y riesgo cardiovascular en pacientes con diabetes mellitus tipo 2. Rev. Méd (Col. Méd. Cir. Guatem) 2020; 159(1): 26-30.